Biopharmaceuticals Manufacturing Consumables Testing Market Size, Share, Trends, and Growth Outlook

Biopharmaceuticals Manufacturing Consumables Testing Market is estimated to increase at a growth rate of 10.5% CAGR over the forecast period from 2024 to 2030.

 

The Biopharmaceuticals Manufacturing Consumables Testing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Chemical Analysis Testing, Enzyme Testing, Stability Testing, Sterility Testing, Others), By Raw Material (Formulation Excipients, Active Pharmaceutical Ingredients (API), Compendial methods (USP/EP/JP) Based, Vendor Qualification Program Support), By Application (Pharma and Biological, Medical Devices, Others), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Development and Manufacturing Organizations (CDMOs), Others).

 

An Introduction to Biopharmaceuticals Manufacturing Consumables Testing Market in 2024

The Biopharmaceuticals Manufacturing Consumables Testing market in 2024 provides essential quality control and assurance services to biopharmaceutical manufacturers, ensuring the safety, efficacy, and regulatory compliance of consumables used in biologic drug manufacturing processes. Consumables testing encompasses the evaluation of raw materials, process intermediates, and final products for contaminants, impurities, and critical quality attributes that may impact product quality or patient safety. Testing services include microbiological analysis, endotoxin testing, sterility testing, bioburden testing, and analytical chemistry testing, conducted in accordance with regulatory guidelines and industry standards. With stringent regulatory requirements and increasing scrutiny of manufacturing processes, biopharmaceutical manufacturers rely on consumables testing laboratories to maintain product quality, comply with regulatory standards, and ensure patient safety. As the biopharmaceutical industry continues to grow and innovate, the demand for consumables testing services is increasing, driving investment and expansion in the biopharmaceuticals manufacturing consumables testing market.

Biopharmaceuticals Manufacturing Consumables Testing Market Trend: Increasing Stringency of Regulatory Requirements

A prominent trend in the Biopharmaceuticals Manufacturing Consumables Testing market is the increasing stringency of regulatory requirements for testing and quality control of consumables used in biopharmaceutical manufacturing. Regulatory authorities, such as the FDA and EMA, continue to impose stringent guidelines and standards to ensure the safety, efficacy, and quality of biopharmaceutical products. This includes rigorous testing of consumables such as single-use bioreactor bags, filtration membranes, tubing, and other components used in bioprocessing. As a result, there is a growing demand for comprehensive testing services to assess the suitability, compatibility, and performance of these consumables in biopharmaceutical manufacturing processes.

Biopharmaceuticals Manufacturing Consumables Testing Market Driver: Growing Adoption of Single-Use Technologies

A key driver for the Biopharmaceuticals Manufacturing Consumables Testing market is the growing adoption of single-use technologies in biopharmaceutical manufacturing. Single-use systems offer several advantages, including reduced risk of cross-contamination, increased flexibility, faster turnaround times, and lower operational costs compared to traditional stainless-steel systems. However, the use of single-use consumables also requires thorough testing to ensure their integrity, reliability, and compatibility with bioprocesses. As biopharmaceutical companies increasingly transition towards single-use technologies to enhance operational efficiency and flexibility, the demand for testing services for these consumables is expected to rise significantly, driving market growth.

Biopharmaceuticals Manufacturing Consumables Testing Market Opportunity: Expansion of Biopharmaceutical Manufacturing Facilities

One potential opportunity in the Biopharmaceuticals Manufacturing Consumables Testing market lies in the expansion of biopharmaceutical manufacturing facilities worldwide. With the growing demand for biologic drugs and the emergence of novel therapies, biopharmaceutical companies are investing in expanding their manufacturing capacities to meet market demand. This expansion includes the construction of new facilities as well as the retrofitting of existing facilities with state-of-the-art equipment and technologies. As these manufacturing facilities increase their use of consumables, there will be a corresponding need for comprehensive testing services to ensure the quality and performance of these consumables throughout the manufacturing process. This presents a significant opportunity for testing laboratories and service providers to offer their expertise and support to biopharmaceutical companies in ensuring the integrity and safety of their manufacturing processes.

 

Biopharmaceuticals Manufacturing Consumables Testing Market Segmentation

By Type

Chemical Analysis Testing

Enzyme Testing

Stability Testing

Sterility Testing

Others

 

By Raw Material

Formulation Excipients

Active Pharmaceutical Ingredients (API)

Compendial methods (USP/EP/JP) Based

Vendor Qualification Program Support

 

By Application

Pharma and Biological

Medical Devices

Others

 

By End-User

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Contract Development and Manufacturing Organizations (CDMOs)

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Biopharmaceuticals Manufacturing Consumables Testing Market Companies

Alcami Corp

Merck KGaA

BioSpectra

Avomeen Analytical Services

Eurofins Scientific

Agilent Technologies

Catalent Inc

Charles River

Gibraltar Laboratories.

Pace Analytical Services LLC

*- List Not Exhaustive

 

Reasons to Buy the Biopharmaceuticals Manufacturing Consumables Testing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the Biopharmaceuticals Manufacturing Consumables Testing Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the Biopharmaceuticals Manufacturing Consumables Testing Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 Biopharmaceuticals Manufacturing Consumables Testing Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global Biopharmaceuticals Manufacturing Consumables Testing Market Size Outlook, $ Million, 2021 to 2030

3.2 Biopharmaceuticals Manufacturing Consumables Testing Market Outlook by Type, $ Million, 2021 to 2030

3.3 Biopharmaceuticals Manufacturing Consumables Testing Market Outlook by Product, $ Million, 2021 to 2030

3.4 Biopharmaceuticals Manufacturing Consumables Testing Market Outlook by Application, $ Million, 2021 to 2030

3.5 Biopharmaceuticals Manufacturing Consumables Testing Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of Biopharmaceuticals Manufacturing Consumables Testing Market Industry

4.2 Key Market Trends in Biopharmaceuticals Manufacturing Consumables Testing Market Industry

4.3 Potential Opportunities in Biopharmaceuticals Manufacturing Consumables Testing Market Industry

4.4 Key Challenges in Biopharmaceuticals Manufacturing Consumables Testing Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global Biopharmaceuticals Manufacturing Consumables Testing Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global Biopharmaceuticals Manufacturing Consumables Testing Market Outlook By Segments

7.1 Biopharmaceuticals Manufacturing Consumables Testing Market Outlook by Segments

By Type

Chemical Analysis Testing

Enzyme Testing

Stability Testing

Sterility Testing

Others

By Raw Material

Formulation Excipients

Active Pharmaceutical Ingredients (API)

Compendial methods (USP/EP/JP) Based

Vendor Qualification Program Support

By Application

Pharma and Biological

Medical Devices

Others

By End-User

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Contract Development and Manufacturing Organizations (CDMOs)

Others

 

8 North America Biopharmaceuticals Manufacturing Consumables Testing Market Analysis And Outlook To 2030

8.1 Introduction to North America Biopharmaceuticals Manufacturing Consumables Testing Markets in 2024

8.2 North America Biopharmaceuticals Manufacturing Consumables Testing Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America Biopharmaceuticals Manufacturing Consumables Testing Market size Outlook by Segments, 2021-2030

By Type

Chemical Analysis Testing

Enzyme Testing

Stability Testing

Sterility Testing

Others

By Raw Material

Formulation Excipients

Active Pharmaceutical Ingredients (API)

Compendial methods (USP/EP/JP) Based

Vendor Qualification Program Support

By Application

Pharma and Biological

Medical Devices

Others

By End-User

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Contract Development and Manufacturing Organizations (CDMOs)

Others

 

9 Europe Biopharmaceuticals Manufacturing Consumables Testing Market Analysis And Outlook To 2030

9.1 Introduction to Europe Biopharmaceuticals Manufacturing Consumables Testing Markets in 2024

9.2 Europe Biopharmaceuticals Manufacturing Consumables Testing Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe Biopharmaceuticals Manufacturing Consumables Testing Market Size Outlook By Segments, 2021-2030

By Type

Chemical Analysis Testing

Enzyme Testing

Stability Testing

Sterility Testing

Others

By Raw Material

Formulation Excipients

Active Pharmaceutical Ingredients (API)

Compendial methods (USP/EP/JP) Based

Vendor Qualification Program Support

By Application

Pharma and Biological

Medical Devices

Others

By End-User

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Contract Development and Manufacturing Organizations (CDMOs)

Others

 

10 Asia Pacific Biopharmaceuticals Manufacturing Consumables Testing Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific Biopharmaceuticals Manufacturing Consumables Testing Markets in 2024

10.2 Asia Pacific Biopharmaceuticals Manufacturing Consumables Testing Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific Biopharmaceuticals Manufacturing Consumables Testing Market size Outlook by Segments, 2021-2030

By Type

Chemical Analysis Testing

Enzyme Testing

Stability Testing

Sterility Testing

Others

By Raw Material

Formulation Excipients

Active Pharmaceutical Ingredients (API)

Compendial methods (USP/EP/JP) Based

Vendor Qualification Program Support

By Application

Pharma and Biological

Medical Devices

Others

By End-User

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Contract Development and Manufacturing Organizations (CDMOs)

Others

 

11 South America Biopharmaceuticals Manufacturing Consumables Testing Market Analysis And Outlook To 2030

11.1 Introduction to South America Biopharmaceuticals Manufacturing Consumables Testing Markets in 2024

11.2 South America Biopharmaceuticals Manufacturing Consumables Testing Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America Biopharmaceuticals Manufacturing Consumables Testing Market size Outlook by Segments, 2021-2030

By Type

Chemical Analysis Testing

Enzyme Testing

Stability Testing

Sterility Testing

Others

By Raw Material

Formulation Excipients

Active Pharmaceutical Ingredients (API)

Compendial methods (USP/EP/JP) Based

Vendor Qualification Program Support

By Application

Pharma and Biological

Medical Devices

Others

By End-User

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Contract Development and Manufacturing Organizations (CDMOs)

Others

 

12 Middle East And Africa Biopharmaceuticals Manufacturing Consumables Testing Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa Biopharmaceuticals Manufacturing Consumables Testing Markets in 2024

12.2 Middle East and Africa Biopharmaceuticals Manufacturing Consumables Testing Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa Biopharmaceuticals Manufacturing Consumables Testing Market size Outlook by Segments, 2021-2030

By Type

Chemical Analysis Testing

Enzyme Testing

Stability Testing

Sterility Testing

Others

By Raw Material

Formulation Excipients

Active Pharmaceutical Ingredients (API)

Compendial methods (USP/EP/JP) Based

Vendor Qualification Program Support

By Application

Pharma and Biological

Medical Devices

Others

By End-User

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Contract Development and Manufacturing Organizations (CDMOs)

Others

 

13 Company Profiles

13.1 Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

Alcami Corp

Merck KGaA

BioSpectra

Avomeen Analytical Services

Eurofins Scientific

Agilent Technologies

Catalent Inc

Charles River

Gibraltar Laboratories.

Pace Analytical Services LLC

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

Biopharmaceuticals Manufacturing Consumables Testing Market Segmentation

By Type

Chemical Analysis Testing

Enzyme Testing

Stability Testing

Sterility Testing

Others

 

By Raw Material

Formulation Excipients

Active Pharmaceutical Ingredients (API)

Compendial methods (USP/EP/JP) Based

Vendor Qualification Program Support

 

By Application

Pharma and Biological

Medical Devices

Others

 

By End-User

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Contract Development and Manufacturing Organizations (CDMOs)

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)